Cargando…
Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review
During 2019, the SARS‐CoV‐2 emerged from China, and during months, COVID‐19 spread in many countries around the world. The expanding data about pathogenesis of this virus could elucidate the exact mechanism by which COVID‐19 caused death in humans. One of the pathogenic mechanisms of this disease is...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431412/ https://www.ncbi.nlm.nih.gov/pubmed/37431777 http://dx.doi.org/10.1002/jcla.24941 |
_version_ | 1785091194708033536 |
---|---|
author | Yousefi, Parastoo Soltani, Saber Siri, Goli Rezayat, Sara Akhavan Gholami, Ali Zafarani, Alireza Razizadeh, Mohamad Hossein Alborzi, Ehsan Mokhtary‐Irani, Golnaz Abedi, Behnam Karampoor, Sajad Tabibzadeh, Alireza Farahani, Abbas |
author_facet | Yousefi, Parastoo Soltani, Saber Siri, Goli Rezayat, Sara Akhavan Gholami, Ali Zafarani, Alireza Razizadeh, Mohamad Hossein Alborzi, Ehsan Mokhtary‐Irani, Golnaz Abedi, Behnam Karampoor, Sajad Tabibzadeh, Alireza Farahani, Abbas |
author_sort | Yousefi, Parastoo |
collection | PubMed |
description | During 2019, the SARS‐CoV‐2 emerged from China, and during months, COVID‐19 spread in many countries around the world. The expanding data about pathogenesis of this virus could elucidate the exact mechanism by which COVID‐19 caused death in humans. One of the pathogenic mechanisms of this disease is coagulation. Coagulation disorders that affect both venous and arterial systems occur in patients with COVID‐19. The possible mechanism involved in the coagulation could be excessive inflammation induced by SARS‐CoV‐2. However, it is not yet clear well how SARS‐CoV‐2 promotes coagulopathy. However, some factors, such as pulmonary endothelial cell damage and some anticoagulant system disorders, are assumed to have an important role. In this study, we assessed conducted studies about COVID‐19‐induced coagulopathy to obtain clearer vision of the wide range of manifestations and possible pathogenesis mechanisms. |
format | Online Article Text |
id | pubmed-10431412 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104314122023-08-17 Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review Yousefi, Parastoo Soltani, Saber Siri, Goli Rezayat, Sara Akhavan Gholami, Ali Zafarani, Alireza Razizadeh, Mohamad Hossein Alborzi, Ehsan Mokhtary‐Irani, Golnaz Abedi, Behnam Karampoor, Sajad Tabibzadeh, Alireza Farahani, Abbas J Clin Lab Anal Review Article During 2019, the SARS‐CoV‐2 emerged from China, and during months, COVID‐19 spread in many countries around the world. The expanding data about pathogenesis of this virus could elucidate the exact mechanism by which COVID‐19 caused death in humans. One of the pathogenic mechanisms of this disease is coagulation. Coagulation disorders that affect both venous and arterial systems occur in patients with COVID‐19. The possible mechanism involved in the coagulation could be excessive inflammation induced by SARS‐CoV‐2. However, it is not yet clear well how SARS‐CoV‐2 promotes coagulopathy. However, some factors, such as pulmonary endothelial cell damage and some anticoagulant system disorders, are assumed to have an important role. In this study, we assessed conducted studies about COVID‐19‐induced coagulopathy to obtain clearer vision of the wide range of manifestations and possible pathogenesis mechanisms. John Wiley and Sons Inc. 2023-07-11 /pmc/articles/PMC10431412/ /pubmed/37431777 http://dx.doi.org/10.1002/jcla.24941 Text en © 2023 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Yousefi, Parastoo Soltani, Saber Siri, Goli Rezayat, Sara Akhavan Gholami, Ali Zafarani, Alireza Razizadeh, Mohamad Hossein Alborzi, Ehsan Mokhtary‐Irani, Golnaz Abedi, Behnam Karampoor, Sajad Tabibzadeh, Alireza Farahani, Abbas Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review |
title | Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review |
title_full | Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review |
title_fullStr | Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review |
title_full_unstemmed | Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review |
title_short | Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review |
title_sort | coagulopathy and thromboembolic events a pathogenic mechanism of covid‐19 associated with mortality: an updated review |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431412/ https://www.ncbi.nlm.nih.gov/pubmed/37431777 http://dx.doi.org/10.1002/jcla.24941 |
work_keys_str_mv | AT yousefiparastoo coagulopathyandthromboemboliceventsapathogenicmechanismofcovid19associatedwithmortalityanupdatedreview AT soltanisaber coagulopathyandthromboemboliceventsapathogenicmechanismofcovid19associatedwithmortalityanupdatedreview AT sirigoli coagulopathyandthromboemboliceventsapathogenicmechanismofcovid19associatedwithmortalityanupdatedreview AT rezayatsaraakhavan coagulopathyandthromboemboliceventsapathogenicmechanismofcovid19associatedwithmortalityanupdatedreview AT gholamiali coagulopathyandthromboemboliceventsapathogenicmechanismofcovid19associatedwithmortalityanupdatedreview AT zafaranialireza coagulopathyandthromboemboliceventsapathogenicmechanismofcovid19associatedwithmortalityanupdatedreview AT razizadehmohamadhossein coagulopathyandthromboemboliceventsapathogenicmechanismofcovid19associatedwithmortalityanupdatedreview AT alborziehsan coagulopathyandthromboemboliceventsapathogenicmechanismofcovid19associatedwithmortalityanupdatedreview AT mokhtaryiranigolnaz coagulopathyandthromboemboliceventsapathogenicmechanismofcovid19associatedwithmortalityanupdatedreview AT abedibehnam coagulopathyandthromboemboliceventsapathogenicmechanismofcovid19associatedwithmortalityanupdatedreview AT karampoorsajad coagulopathyandthromboemboliceventsapathogenicmechanismofcovid19associatedwithmortalityanupdatedreview AT tabibzadehalireza coagulopathyandthromboemboliceventsapathogenicmechanismofcovid19associatedwithmortalityanupdatedreview AT farahaniabbas coagulopathyandthromboemboliceventsapathogenicmechanismofcovid19associatedwithmortalityanupdatedreview |